1800 202 8726
Thyroid nodules

Does Every Thyroid Nodule — Need an FNAC?

Being told you have a thyroid nodule is frightening. Most nodules are benign and most are never sampled. What decides whether yours needs an FNAC is a specific set of ultrasound features — not the finding of a nodule alone.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Most nodules are benign — The vast majority of thyroid nodules found on ultrasound are not cancer, whatever their size.
  • Ultrasound features guide the decision — Composition, shape, margins, and calcifications on your scan matter more than size alone.
  • TI-RADS gives a risk score — Your radiologist uses a validated scoring system to determine whether sampling would add useful information.
  • Observation is active, not passive — Watching a nodule means repeat scans on a schedule, with a clear plan to act if anything changes.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Most thyroid nodules do not need an FNAC. The decision is guided by ultrasound features scored using TI-RADS, and the nodule's size. Low-risk nodules are observed on a surveillance schedule, not sampled. Only nodules with features suggesting a meaningful probability of malignancy reach the threshold where biopsy adds useful information.

What decides whether your nodule needs sampling?

The decision comes from two things together: the features your radiologist sees on ultrasound, and the size of the nodule. Neither factor alone tells the full story.

Ultrasound features are scored using ACR TI-RADS — Thyroid Imaging Reporting and Data System. The score reflects the nodule's composition, echogenicity, shape, margins, and whether it contains calcifications. A low TI-RADS score carries a very small probability of malignancy and does not usually require sampling regardless of size.

A higher score — or features that concern the radiologist even without a formal score — is where sampling enters the conversation. Even then, size still matters alongside the score. Small nodules with suspicious features may be watched rather than biopsied, because sampling at that size can introduce more uncertainty than it resolves.

When is watching the right choice?

For most nodules — including the majority found incidentally on a scan done for an unrelated reason — a follow-up ultrasound is the right plan, not a biopsy. ATA and ACR guidance both recognise observation as the appropriate path for low-risk or very small nodules.

Observation is not passive. It means a repeat scan at an interval your doctor sets, watching for meaningful change in size or ultrasound appearance. If the nodule changes in a way that raises its score, the plan changes too.

Your age, any history of radiation to the neck, and family history of thyroid cancer are also weighed alongside the TI-RADS score when the decision sits on the border between watching and sampling.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What else affects whether your nodule needs a biopsy?

  • Tell your doctor if you have had previous radiation to your neck or head.
  • Mention any close family member who has been diagnosed with thyroid cancer.
  • Report any lump you can now feel in your neck that was not noted on the scan.
  • Note any voice change or new difficulty swallowing since the scan was done.
  • Say if you are pregnant or planning to become pregnant — timing can matter.
  • List any supplements containing iodine or thyroid-related ingredients.

What should you know if sampling is not recommended?

Why would a doctor not want to biopsy something they found?

Recommending observation is evidence-based restraint, not hesitation. Sampling a low-TI-RADS nodule is unlikely to change the management plan, and every biopsy carries a small risk of discomfort or bleeding. ACR and ATA guidance sets the biopsy threshold specifically to protect you from unnecessary procedures. A nodule on surveillance is monitored — not ignored.

What if the nodule grows on the follow-up scan?

Growth alone does not mean cancer. Benign nodules can enlarge slowly over years. What your doctor is watching for is significant growth within the follow-up interval, or a change in the ultrasound character of the nodule. If either happens, the recommendation may shift from observation to sampling. This is exactly what the surveillance schedule is designed to detect — which is why attending every follow-up scan matters.

My FNAC result says indeterminate — what does that mean?

Indeterminate most often means a Bethesda III or IV result. These categories describe cells that do not look clearly benign or clearly cancerous under the microscope. NCCN and ATA both note that the probability of malignancy in these categories is not high enough to make surgery automatic. Molecular testing of the biopsy cells is sometimes used next to narrow the question before any decision is made.

Can a nodule that was not biopsied turn out to be cancer?

Yes, and this is the honest answer to the fear behind the question. TI-RADS-guided observation concentrates biopsy resources on nodules where the probability of cancer justifies the procedure. It cannot offer certainty — no clinical approach can. Most thyroid cancers grow slowly, and the evidence does not consistently show that finding them through surveillance rather than incidentally changes outcomes. Your specialist can explain what this means for your specific nodule.

Should I get a second opinion on the ultrasound score?

A second opinion is always reasonable, and it is particularly useful when the TI-RADS score sits in the middle range where the biopsy-versus-observe decision is less clear-cut. What a reviewer needs is the original scan images — not just the written report — because the score depends on reading the images directly. If you seek one, bring your images on a CD or USB alongside the printed report.

Explore 133 more Biopsy by Body Part topics

HUB — Biopsy by Body Part

All Biopsy by Body Part →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Can a thyroid nodule go away on its own?

Cysts — nodules filled mostly with fluid — can shrink or resolve over time. Solid nodules generally do not disappear. A nodule placed under surveillance stays on the schedule until your doctor is satisfied that the risk is low enough to stop watching it. That decision is made on the basis of the latest scan findings, not assumed because nothing feels different to you.

What is TI-RADS and who calculates the score?

TI-RADS stands for Thyroid Imaging Reporting and Data System. The ACR version — the one most widely used — scores each nodule on five ultrasound features: composition, echogenicity, shape, margins, and calcifications. Each feature adds points; the total determines the risk category, which sets the size threshold for recommending a biopsy. Your radiologist calculates it from the scan images, and the score and recommendation appear in your ultrasound report.

How often will I need a follow-up scan if my nodule is being watched?

The interval depends on the TI-RADS category. Lower-risk nodules may need only one or two follow-up scans before being discharged from surveillance if nothing changes. Higher-risk categories are followed more closely, especially in the first few years. Your doctor will set a specific interval after reviewing your score. Attending every scan matters — a nodule stable over several years tells a different clinical story from one that has not been checked.

What blood tests are done alongside a thyroid ultrasound?

A TSH — thyroid-stimulating hormone — test is done in most protocols alongside the scan. It tells your doctor how the thyroid gland is functioning overall. A nodule in a gland producing too much or too little hormone changes the clinical picture and influences the plan. Blood tests cannot diagnose cancer in a nodule; they assess gland function, not malignancy.

Can I have the FNAC done at a CION centre if my nodule needs sampling?

Yes. Thyroid FNAC is performed at CION centres as a day procedure — no hospital admission is required. If your ultrasound report suggests sampling is warranted, your treating doctor will refer you. Imaging scans such as PET-CT, if needed later, are coordinated with partner imaging centres. Your team will explain each step in sequence so you are not navigating the process alone.

At what point should I see a specialist rather than just having a repeat scan?

If your ultrasound scores your nodule in a higher TI-RADS category and biopsy is being considered, your doctor will usually refer you to a specialist. Other reasons to see one sooner include a voice change, difficulty swallowing, a lump you can feel in your neck, an abnormal TSH result, or a previous FNAC that returned an indeterminate or suspicious result.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation